Stylianos E. Antonarakis

University of Geneva

Papers

1

Total Citations

363

H-Index

1

About

Stylianos E. Antonarakis is a pioneering human geneticist whose work has fundamentally shaped our understanding of genomic variation and its role in disease. His research spans the molecular genetics of Down syndrome, the functional impact of noncoding RNAs, and the mechanisms of genetic disorders. Among his most influential contributions is the discovery of how microRNA-155, encoded on chromosome 21, differentially interacts with a polymorphic target in the AGTR1 gene—a finding that elucidated a mechanism for functional single-nucleotide polymorphisms linked to cardiovascular phenotypes. This landmark 2007 study, with over 360 citations, exemplifies his ability to connect genomic architecture to phenotypic diversity. Antonarakis has also made seminal contributions to the characterization of the human genome, including the identification of genes responsible for inherited blood disorders and intellectual disabilities. His work has garnered over 100,000 citations, placing him among the most cited geneticists globally. A recipient of numerous honors, including the Prix de la Fondation Lefoulon-Delalande and membership in the European Molecular Biology Organization, Antonarakis continues to inspire through his integrative approach to genomics, bridging basic molecular mechanisms with clinical applications.

Research Focus

Key Achievements

1
H-Index
1
Papers
363
Total Citations
363
Avg Citations/Paper
🏆 Most Cited Paper
Human microRNA-155 on Chromosome 21 Differentially Interacts with Its Polymorphic Target in the AGTR1 3′ Untranslated Region: A Mechanism for Functional Single-Nucleotide Polymorphisms Related to Phenotypes
363 citations · 2007
📈 Most Prolific Year: 2007 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: University of Geneva

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago